(arom-CH3), 28.8, 29.1 (C(CH3)3), 41.8, 45.7, 48.0, 50.2, 52.7,
54.2, 55.3 (N–CH2–), 67.0, 79.6, 79.8 ((CH3)3CO), 132.5, 133.8,
140.5, 143.0, 155.6 (aromC). Found C, 59.04; H, 8.42; N, 9.84;
O, 17.45%. C34H59N5O8S requires C, 59.26; H, 8.57; N, 10.24; O,
17.54%. M = 2188.92.
4.70 mmol) were added. To the mixture, which was stirred for
3 h, then degassed and backfilled with N2, a pre-cooled solution
of tris(2-aminoethyl)amine (0.19 g, 1.30 mmol) and triethylamine
(0.84 g, 8.30 mmol) in CH2Cl2 (10 ml) was added via syringe.
The reaction solution was stirred for a further 3 h at 0 ◦C and
then at r.t. overnight. The solid product was filtered off and the
volatiles were removed in vacuo to leave a foamy off-white solid.
Acetonitrile (10 ml) was added and the flask was cooled for 2 h
at −18 ◦C. The subsequent precipitate was filtered off and the
solution returned to the freezer for a further 16 h. Any further
precipitate was then filtered off and the solvent removed from
the product in vacuo. The product was further purified using
a short silica gel 60 column eluting with CH2Cl2–MeOH (80 :
20). The product was a pale white solid. Yield: 1.23 g (55%).
Tris[3-aza-5-(1,4,7,10-tetraazacyclododec-1-yl)pentyl]amine (L1).
Compound 7 (1.5 g, 0.68 mmol) was dissolved in a mixture of
CH2Cl2 (15 ml), TFA (4 ml) and phenol (1.3 g) and stirred for 14 h
at r.t. to cleave the boc groups. The triflate salt was precipitated
with diethyl ether and the resulting solid dissolved in a mixture
of CF3COOH–trifluoromethane sulfonic acid (9 : 1, 40 ml) and
stirred for 48 h. The triflate salt was precipitated from the dark
red solution by adding an excess of diethyl ether (200 ml). It
was washed and centrifuged repeatedly with diethyl ether until
the washing solution was colourless. The remaining solid was
dried in vacuo and dissolved in a minimum amount of water. The
free base was obtained from ion exchange chromatography with
Dowex 2 charged with OH ions after evaporation of the solvent.
It was isolated as a light brown semi-solid. Yield: 440 mg (87%).
1H-NMR (CDCl3): dH 2.50–2.66 (m, 36 H, N–CH2 + 12 NH);
13C-NMR (CDCl3): dC 44.0, 44.9, 45.6, 46.1, 46.7, 51.4, 53.7, 53.7
(N–CH2).
1
ESI-MS: m/z 1726 (M, 100). H-NMR (CDCl3): dH 1.46, 1.49
(2 s, 81 H, (CH3)3C), 2.37 (m, 6 H, CH2C(O)N), 2.55–2.75 (2
m, 18 H, NCH2), 3.02 (m, 6 H, NCH2CH2NC(O)), 3.25–3.55 (3
broad m, 42 H, NCH2 of cyclen and NCH2CH2NC(O)); 13C-NMR
(CDCl3): dC 28.9, 29.1 ((CH3)3CO), 38.00 (C(O)NCH2), 48–52 (all
NCH2), 79.8 [(CH3)3CO], 157.2, 155.8 (NC(O)O of BOC), 173.0
(CH2C(O)NCH2). TLC: CH2Cl2–MeOH (80 : 20) Rf = 0.56.
Tris-[3-aza-6-(1,4,7,10-tetraazacyclododec-1-yl)hexyl]amine (L2).
Compound 9 (1 g, 0.58 mmol) was dissolved in dry thf (10 ml)
under an argon atmosphere. A 1 M solution of BH3·thf (12 ml,
12 mmol) was added using a syringe and the solution refluxed for
The free base was converted to the hydrochloride salt by
dissolving it (0.12 g, 0.16 mmol) in MeOH (15 ml) and adding
HCl (36%, 1.5 ml). After cooling at −18 ◦C for 18 h the colourless
product was filtered off, washed with cold MeOH and diethyl ether
◦
48 h under argon. To the solution, which was cooled to 0 C, a
1
mixture of methanol and water was slowly added. The solution
was evaporated to dryness and conc. HCl–H2O (1 : 1, 15 ml) was
added. The flask was heated to 110 ◦C for 1 h with the solid
dissolving after a short period of time. The acid was evaporated
yielding a white solid. The solid was dissolved in water and put
through a Dowex 2 ion-exchange column in the OH− form. When
the water was evaporated, a pale yellow oil resulted which still
contained thf. Some of this thf can be removed by gel filtration
with Sephadex-15 and water as an eluent. The product was dried
in vacuo. Yield: 390 mg (86%) (with some thf). ES MS: m/z 784
and dried in vacuo. Yield: 190 mg (89.4%). H-NMR (D2O): dH
3.10–2.80 (3 m, 18 H, R2N–CH2–H), 3.30–3.10 (3 m, 18 H, H+N–
CH2–H); 13C-NMR (CDCl3): dC 41.30. 42.27, 43.02, 43.64, 47.75,
47.47, 48.98 (N–CH2–), 48.82 (MeOH). Found C, 32.77; H, 7.81;
N, 16.68%. C36H100N16Cl16. 1 MeOH requires C, 32.72; H, 7.73; N,
16.52%. M = 1356.50.
3-[4,7,10-Tris(t-butyloxycarbonyl)-1,4,7,10-tetraazacyclododec-
1-yl]propionic acid (8). To a solution of 3-(1,4,7,10-tetra-
azacyclododec-1-yl)propionic acid as the lithium salt (2.5 g,
10.0 mmol), dissolved in DMF (350 ml), a solution of di-t-
butylcarbonate (6.5 g, 29.8 mmol) in DMF (100 ml) was added
slowly over 60 min. The solution was then stirred for 2 h. The
solvent was evaporated. The crude product mixture was purified
by flash chromatography on a Silicagel 60 column using CH2Cl2–
MeOH (80 : 20) as an eluent. The product was a pale yellow oil
which foams when dried under vacuum. Yield 3.4 g (62.5%). FAB-
MS: m/z 545 (M + 1, 30), 307 (15), 245 (M − 3BOC, 45), 154 (tBu2,
100), 136 (70), 57 (tBu, 75). 1H-NMR (CDCl3): dH 1.48, 1.49 (2 s,
ratio 2 : 1, 27 H, (CH3)3C), 2.52 (t, 2 H, 3J = 6.8 Hz, CH2CO2H),
2.78–2.72 (m, 4 H, NCH2), 2.97 (m, 2 H, a-CH2), 3.44–3.33 (m,
8 H, NCH2 of cyclen), 3.49–3.56 (m, 4 H, NCH2 of cyclen); 13C-
NMR (CDCl3): dC 28.9 ((CH3)3CO), 29.1, 48.2, 50.1, 53.8, (all
NCH2 of cyclen and NCH2CH2CO2H), 79.9, 80.3 ((CH3)3CO),
155.9, 156.5 (NC(O)O), 175.5 (CO2H). TLC (80 : 20 = CH2Cl2–
MeOH) Rf = 0.6.
1
(M, 100), 629 (M·H2O − cyclen, 25), 612 (M − cyclen, 60). H-
NMR (D2O): dH 1.57 (m, 6 H, NCH2CH2CH2N of amine), 2.38–
2.75 (br m, 72 H, all NCH2 of cyclen and amine); 13C-NMR
(D2O, DMSO): dC 27.6 (CH2CH2CH2), 45.3 (CH2 of C6, C7), 45.8
(CH2 of C5, C8), 47.1 (CH2 of C2, C9), 47.6 (N(H)CH2CH2CH2),
48.9 (N(H)CH2CH2N), 52.0 (CH2 of C1, C10), 53.6 (NCH2 a to
cyclen), 54.8 (CH2CH2 a to 3N). IR KBr disk (free base) m/cm−1:
3390, 2934, 2833, 1567, 1463, 1407, 1351, 1296, 1111, 1065, 814.
1-[(2-(Mesitylenesulfonyl-2-methylaminoethyl)]-1,4,7,10-tetra-
azacyclododecane (10). To compound 6 (2.5 g, 3.58 mmol)
dissolved in CH2Cl2 (25 ml) a NaH suspension (65%, 143 mg,
3.87 mmol) and CH3I (0.3 ml, 4.8 mmol) were added. The mixture
was refluxed for 6 h. After cooling to r.t. the suspension was
washed with H2O (10 ml), the organic phase dried over Na2SO4,
filtered and evaporated to dryness to yield 1-(2-mesitylenesulfonyl-
2-methylaminoethyl)-4,7,10-tris(tert-butyloxycarbonyl)-1,4,7,10-
tetraazacyclododecane, which was dissolved in a mixture of
CH2Cl2 (50 ml), TFA (4 ml) and phenol (1.3 g) and stirred
for 14 h at r.t. To complete the reaction the triflate salt was
dissolved in a mixture of CF3COOH–trifluoromethanesulfonic
acid (40 ml, 9 : 1) and stirred for 48 h. Thereafter, the triflate salt
was precipitated from the dark red solution by adding an excess of
Tris-[3-aza-4-oxo-6-{4,7,10-tris(t-butyloxycarbonyl)-1,4,7,10-
tetraazacyclododec-1-yl}hexyl]amine (9). 1-(4,7,10-Tris(tert-bu-
tyloxycarbonyl)-1,4,7,10-tetraazacyclododec-1-yl)-propionic acid
8 (2.14 g, 3.96 mmol) was dissolved in CH2Cl2 (10 ml) and cooled
to 0 ◦C. To this solution, N-hydroxysuccinimide (NHS, 1.0 g,
8.69 mmol) and N,Nꢀ-dicyclohexyl carbodiimide (DCC, 0.97 g,
This journal is
The Royal Society of Chemistry 2007
Dalton Trans., 2007, 4797–4810 | 4799
©